Christian T.
- Country
- Germany
- Department
- Klinik und Poliklinik für Urologie
Research Overview
- A Randomized Controlled Trial Evaluating the Efficacy of Lutetium (177Lu) Vipivotide Tetraxetan in Patients with Metastatic Hormone-Sensitive Prostate Cancer Receiving Androgen Deprivation Therapy
- Phase Ib/II Study of AMO959 with Lutetium (177Lu) Vipivotide Tetraxetan and Combination Therapy in Patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (KEYNOTE-564)
Data & Insights
Has run more than one trial at 234 of 456 partner sites.
Specializations
Prostate Cancer Research
Specializes in investigating advanced therapeutic approaches for metastatic castration-sensitive prostate cancer (mCSPC) and metastatic castration-resistant prostate cancer (mCRPC). Focused on innovative hormone therapy strategies and targeted treatments for high-risk cases.
- Hormonal Therapy Optimization
- Novel Therapeutic Combinations
- Treatment of Advanced Disease
Particularly interested in developing personalized treatment approaches for patients with specific genetic mutations affecting treatment response.
Bladder Cancer Interventions
Conducts research in muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer, with expertise in novel delivery systems and targeted therapies. Explores innovative treatment combinations including immunotherapy approaches.
- Intravesical Treatment Development
- Advanced Urothelial Cancer Management
- Targeted Therapeutic Solutions
Focuses on developing localized treatment options and investigating combination therapies for improved patient outcomes.
Renal Cell Carcinoma Studies
Investigates therapeutic strategies for metastatic renal cell carcinoma, with particular emphasis on adjuvant treatments and combination therapies. Explores novel immunotherapy approaches and targeted agents.
- Post-Nephrectomy Treatment
- Immunotherapy Applications
- Disease-Free Survival Enhancement
Specializes in developing treatment protocols that combine multiple therapeutic modalities for optimal patient care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.